KPF
NXTM

K2 Principal Fund’s NxStage Medical Inc. NXTM Stock Holding History

K2 Principal Fund’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-44,565
Closed -$1.24M – 414
2018
Q2 		$1.24M Sell
44,565
-107,229
-71% -$2.88M 0.1% 205
2018
Q1 		$3.77M Sell
151,794
-51,312
-25% -$1.25M 0.21% 124
2017
Q4 		$4.92M Buy
+203,106
New +$5.35M 0.36% 74

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

K2 Principal Fund's NXTM Position: Q3 2018 in Review

K2 Principal Fund sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 44,565 shares — an estimated $1.24M sold.

K2 Principal Fund first reported a position in NXTM in Q4 2017 and held it in 3 quarters. The position peaked at $4.92M in Q4 2017. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • K2 Principal Fund reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • K2 Principal Fund sold 44,565 NxStage Medical Inc. shares in Q3 2018, an estimated $1.24M.
  • K2 Principal Fund first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 3 quarters.
  • K2 Principal Fund's NxStage Medical Inc. position peaked at $4.92M in Q4 2017.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on K2 Principal Fund's 13F filing for Q3 2018, filed 13 Nov 2018.